Curtiss-Wright Corporation

Based on a comprehensive review of Curtiss-Wright (CW), the stock presents a compelling but high-stakes investment case, characterized by strong operational performance countered by a demanding valuation.

Technical Analysis shows exceptional momentum, with the stock near its 52-week high after a 160% rally from its low. Recent short-term gains of over 29% in three months significantly outpace the market. However, trading at 96% of its high after such a parabolic rise places it in overbought territory, signaling a heightened near-term risk of consolidation or a pullback.

Fundamentals are robust, featuring solid revenue growth, strong and consistent profitability with net margins around 14.5%, and excellent financial health marked by low debt and strong cash flow. A modest Return on Equity (5.4%) and a lengthy cash conversion cycle (~135 days) point to areas for operational improvement, but the core business model appears sound and financially disciplined.

Valuation is the primary concern. With a TTM P/E of 53.5 and an extreme EV/EBITDA of 116, the stock prices in tremendous future growth. The high PEG ratio of 3.35 suggests this growth premium may be excessive. While direct peer data is unavailable, these multiples are stretched relative to general market norms, indicating the stock is overvalued on current metrics.

Risk Assessment is moderate. The stock's beta below 1 and a contained maximum drawdown show it has been less volatile than the market. The absence of significant short interest reduces squeeze risk but may hint at lower liquidity.

Final Buy Recommendation: Curtiss-Wright operates a high-quality, profitable business with strong momentum, making it a worthy candidate for a growth-oriented portfolio. However, its extreme valuation creates significant vulnerability. A buy recommendation is only suitable for investors with a high risk tolerance and a long-term horizon, who are comfortable entering at a peak with the understanding that near-term volatility is likely. Investors should consider waiting for a meaningful price correction to improve the risk-reward profile.

RockFlow Model Forecast: Three Scenarios for 2026

Based on a 12-month outlook, Curtiss-Wright (CW) is positioned for continued fundamental strength but faces significant valuation headwinds that will likely cap near-term upside.

Key catalysts will be the execution of its backlog in the resilient Defense & Aerospace sectors, potential for margin expansion from operational improvements, and strategic capital deployment through M&A or share buybacks. Potential risks are predominantly valuation-based, with the stock highly vulnerable to a de-rating if growth momentum falters or if broader market multiples contract; a significant pullback from overbought technical levels is a near-term risk. Given the extreme current multiples and lack of a clear analyst target, a prudent target price range is $650 - $750, reflecting the high-quality business model but also the substantial premium already priced into the stock.

Wall Street Consensus

Most Wall Street analysts are optimistic about Curtiss-Wright Corporation's 12-month outlook, with consensus target around $696.99, indicating expected upside potential.

Overall, CW has investment potential but also faces challenges. Here are key factors to weigh before investing.

CW has demonstrated exceptionally strong long-term performance, with its current price near the 52-week high representing a gain of over 160% from its low.

The stock has delivered outstanding short-term returns, surging 29.46% over the last three months and significantly outperforming the market by over 32%, despite a minor 1.43% pullback in the most recent month.

Currently trading at approximately 96% of its 52-week high, the stock is in a technically strong position; however, this proximity to the peak, combined with its recent parabolic rise, suggests it is in overbought territory and may be due for a consolidation or correction.

Revenue & Profitability: CW demonstrated solid revenue growth, with Q4 2025 revenue increasing to $947 million from $869 million in Q3. Profitability remains strong, with a consistent net profit margin of approximately 14.5% in Q4, supported by a healthy gross profit margin of 37.5%. The operating profit margin of 19.4% indicates effective control over core operating expenses.

Financial Health: The company maintains a conservative capital structure, evidenced by a low debt ratio of 0.25 and a manageable debt-to-equity ratio of 0.52. Strong interest coverage of 15.3x and a positive operating cash flow to sales ratio of 0.37 suggest ample capacity to service its obligations and fund operations internally.

Operational Efficiency: Operational metrics show mixed signals. The return on equity (ROE) of 5.4% is modest, which is partly a function of a low asset turnover of 0.18, indicating less efficient use of assets to generate sales. However, the cash conversion cycle of approximately 135 days highlights a significant working capital investment, primarily driven by high days sales outstanding and days inventory outstanding.

Valuation Level: CW's TTM PE ratio of 53.47 and forward PE of 37.15 are exceptionally high, indicating a significant growth premium is priced into the stock. The elevated PEG ratio of 3.35 suggests this premium may not be fully justified by its expected earnings growth rate. Furthermore, the extreme EV/EBITDA of 116.1 and high PB ratio of 10.22 reinforce the conclusion that the stock is overvalued based on its current earnings and asset base.

Peer Comparison: A definitive peer comparison cannot be performed due to the unavailability of industry average data. However, the provided multiples are so high that they would likely far exceed typical industry benchmarks for most sectors. Therefore, even without specific averages, CW's valuation appears stretched relative to broader market norms.

Volatility Risk: CW exhibits moderate volatility risk, with a Beta of 0.914 indicating it is slightly less volatile than the broader market. The stock's one-year maximum drawdown of -14.17% is relatively contained, suggesting it has demonstrated reasonable resilience during recent market downturns.

Other Risks: A notable positive is the absence of reported short interest, which reduces the risk of a short squeeze and indicates a lack of significant bearish sentiment. However, the lack of short interest data may also correlate with lower trading liquidity, which could pose challenges in executing large orders without impacting the stock price.